May 7-8, 2026
Politecnico di Milano
Piazza Leonardo da Vinci, 31 - Milan, Italy
Abstract
The European Interdisciplinary Society for AI in Cancer Research (ESAC) will hold its inaugural Annual Meeting on May 7 and 8, 2026 in Milan, hosted at the Politecnico di Milano. It represents an important milestone for our community and is designed as a high-level scientific forum to present recent impactful innovations across all facets of AI applications in oncology, and represents an important occasion to network with a diverse community of peers.
The program brings together leading experts in clinical oncology, computational sciences, imaging specialists, translational research, and experts in ethics and regulatory science; sessions include:
- Foundations for AI in cancer and the integration of multi-omics and multimodal data
- AI for clinical applications
- Methodological developments in explainable, trustworthy AI
- Applications of large language models and agentic AI systems in oncology
- AI-enabled drug discovery, prevention, and biomarker development
- Digital health solutions and real-world data approaches in clinical oncology
- Cross-cutting topics from technology transfer to ethics and patient-cantered research.
ESAC is a pan-European and multidisciplinary initiative focused on advancing and supporting the responsible, scientifically rigorous applications of AI in cancer research and treatment.